Sign in

CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203435077
Phone
8587318389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
  1. 4 Open-market buy President and CEO bought 6,000 shares at $4.27 ($25,620)
  2. 8-K Event Regulation FD disclosure
  3. 4 Open-market sale General Counsel sold 322 shares at $3.62 ($1,166)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale Director sold 8,447 shares at $3.64 ($30,739)
  7. 8-K Event Other events
  8. 424B5 Offering Prospectus
  9. 8-K Event Regulation FD disclosure
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 8-K Event Executive or director change · Shareholder vote results
  19. 8-K Event Other events
  20. DEF 14A Proxy Proxy Statement

Page 17 of 38 · 755 filings